Cite

HARVARD Citation

    Lu, D. et al. (2020). Integrated Two‐Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non‐Hodgkin Lymphoma. CPT: pharmacometrics & systems pharmacology. pp. 48-59. [Online]. 
  
Back to record